{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T05:52:27Z","timestamp":1775627547591,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Infectious Diseases"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1016\/s1473-3099(02)00222-0","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T15:36:48Z","timestamp":1027611408000},"page":"156-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":255,"title":["Superantigens: microbial agents that corrupt immunity"],"prefix":"10.1016","volume":"2","author":[{"given":"Martin","family":"Llewelyn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S1473-3099(02)00222-0_bib1","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2185544","article-title":"The staphylococcal enterotoxins and their relatives","volume":"248","author":"Marrack","year":"1990","journal-title":"Science"},{"key":"10.1016\/S1473-3099(02)00222-0_bib2","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.172.3.981","article-title":"Selective expansion of T-cells expressing V\u03b22 in toxic shock syndrome","volume":"172","author":"Choi","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/S1473-3099(02)00222-0_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1084\/jem.177.1.175","article-title":"Two adjacent residues in staphylococcal enterotoxins A and E determine T cell receptor V beta specificity","volume":"177","author":"Hudson","year":"1993","journal-title":"J. Exp Med"},{"key":"10.1016\/S1473-3099(02)00222-0_bib4","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/368711a0","article-title":"Three- dimensional structure of a human class II histocompatibility molecule complexed with superantigen","volume":"368","author":"Jardetzky","year":"1994","journal-title":"Nature"},{"key":"10.1016\/S1473-3099(02)00222-0_bib5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0966-842X(00)89011-3","article-title":"Bacterial superantigens in human disease: structure, function and diversity","volume":"3","author":"Ulrich","year":"1995","journal-title":"Trends Microbiol"},{"key":"10.1016\/S1473-3099(02)00222-0_bib6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.immunol.17.1.435","article-title":"The structural basis of T cell activation by superantigens","volume":"17","author":"Li","year":"1999","journal-title":"Anna Rev Immunol"},{"key":"10.1016\/S1473-3099(02)00222-0_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1600-065X.1993.tb01529.x","article-title":"Signal transduction by microbial superantigens via MHC class II molecules","volume":"131","author":"Chatila","year":"1993","journal-title":"Immunol Rev"},{"key":"10.1016\/S1473-3099(02)00222-0_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1084\/jem.175.1.91","article-title":"T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor","volume":"175","author":"Miethke","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/S1473-3099(02)00222-0_bib9","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1128\/iai.62.9.3731-3738.1994","article-title":"Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B","volume":"62","author":"Norrby-Teglund","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/S1473-3099(02)00222-0_bib10","doi-asserted-by":"crossref","first-page":"8884","DOI":"10.1073\/pnas.87.22.8884","article-title":"Induction of specific clonal anergy in human T lymphocytes by Staphylococcus aureu enterotoxins","volume":"87","author":"O'Hehir","year":"1990","journal-title":"Proc NatlAcad Sci USA"},{"key":"10.1016\/S1473-3099(02)00222-0_bib11","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.4049\/jimmunol.150.9.3776","article-title":"Acquired resistance to superantigen-induced T cell shock. V beta selective T cell unresponsiveness unfolds directly from a transient state of hyperreactivity","volume":"150","author":"Miethke","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/S1473-3099(02)00222-0_bib12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/349245a0","article-title":"Programmed cell death and extrathymic reduction of Vbeta8+ CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B","volume":"349","author":"Kawabe","year":"1991","journal-title":"Nature"},{"key":"10.1016\/S1473-3099(02)00222-0_bib13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1128\/iai.36.1.123-128.1982","article-title":"Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C","volume":"36","author":"Schlievert","year":"1982","journal-title":"Infect Immun"},{"key":"10.1016\/S1473-3099(02)00222-0_bib14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0891-5520(05)70081-7","article-title":"Structure and function of streptococcal and staphylococcal superantigens in septic shock","volume":"13","author":"Bannan","year":"1999","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/S1473-3099(02)00222-0_bib15","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.4049\/jimmunol.144.12.4501","article-title":"Relationship between enterotoxic- and T lymphocyte-stimulating activity of staphylococcal enterotoxin B","volume":"144","author":"Alber","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/S1473-3099(02)00222-0_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-1605(00)00377-9","article-title":"Staphylococcal enterotoxins","volume":"61","author":"Balaban","year":"2000","journal-title":"Int J Food Microbiol"},{"key":"10.1016\/S1473-3099(02)00222-0_bib17","first-page":"647","article-title":"Induction of acute inflammation in vivo by staphylococcal superantigens I: leukocyte recruitment occurs independently of T lymphocytes and major histocompatibility complex class II molecules","volume":"78","author":"Diener","year":"1998","journal-title":"Lab Invest"},{"key":"10.1016\/S1473-3099(02)00222-0_bib18","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1046\/j.1365-2958.1999.01525.x","article-title":"Molecular analysis of the role of streptococcal pyrogenic exotoxin A (SPEA) in invasive soft-tissue infection resulting from Streptococcus pyogenes","volume":"33","author":"Sriskandan","year":"1999","journal-title":"Mol Microbiol"},{"key":"10.1016\/S1473-3099(02)00222-0_bib19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev.micro.55.1.77","article-title":"Toxic shock syndrome and bacterial superantigens: an update","volume":"55","author":"McCormick","year":"2001","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/S1473-3099(02)00222-0_bib20","doi-asserted-by":"crossref","first-page":"875","DOI":"10.7326\/0003-4819-96-6-875","article-title":"Toxic shock syndrome surveillance in the United States, 1980 to 1981","volume":"96","author":"Reingold","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/S1473-3099(02)00222-0_bib21","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.1993.03500030088038","article-title":"Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition","volume":"269","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/S1473-3099(02)00222-0_bib22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/clinids\/14.1.2","article-title":"Invasive group A streptococcus infections","volume":"14","author":"Stevens","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S1473-3099(02)00222-0_bib24","doi-asserted-by":"crossref","first-page":"E60","DOI":"10.1542\/peds.105.5.e60","article-title":"Invasive group A streptococcal disease in children and association with varicella zoster virus infection. Ontario Group A Streptococcal Study Group","volume":"105","author":"Laupland","year":"2000","journal-title":"Pediatrics"},{"issue":"suppl","key":"10.1016\/S1473-3099(02)00222-0_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/jac\/45.suppl_1.3","article-title":"Group A streptococci in the 1990s","volume":"45","author":"Efstratiou","year":"2000","journal-title":"J. Antimicrob Chemother"},{"key":"10.1016\/S1473-3099(02)00222-0_bib26","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3201\/eid0506.990611","article-title":"Toxic shock syndrome in the United States: surveillance update, 1979-1996","volume":"5","author":"Hajjeh","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/S1473-3099(02)00222-0_bib27","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1172\/JCI10396","article-title":"Immunopathophysiological aspects of an emerging neonatal infectious disease induced by a bacterial superantigen","volume":"106","author":"Takahashi","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/S1473-3099(02)00222-0_bib28","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/314872","article-title":"Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome","volume":"180","author":"Eriksson","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/S1473-3099(02)00222-0_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1600-065X.1998.tb01196.x","article-title":"Structure-function studies of T-cell receptor-superantigen interactions","volume":"163","author":"Li","year":"1998","journal-title":"Immunol Rev"},{"issue":"suppl","key":"10.1016\/S1473-3099(02)00222-0_bib30","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1007\/BF01540888","article-title":"The potential role of bacterial superantigens in the pathogenesis of Kawasaki syndrome","volume":"15","author":"Leung","year":"1995","journal-title":"J Clin Immunol"},{"key":"10.1016\/S1473-3099(02)00222-0_bib31","first-page":"170","article-title":"Report of the National Institutes of Health Workshop on Kawasaki Disease","volume":"26","author":"Barren","year":"1999","journal-title":"Rheumatol"},{"key":"10.1016\/S1473-3099(02)00222-0_bib32","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1128\/IAI.68.6.3630-3634.2000","article-title":"Pyrogenic toxin superantigen site specificity in toxic shock syndrome and food poisoning in animals","volume":"68","author":"Schlievert","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/S1473-3099(02)00222-0_bib33","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1084\/jem.185.8.1447","article-title":"Transcytosis of staphylococcal superantigen toxins","volume":"185","author":"Hamad","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/S1473-3099(02)00222-0_bib34","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0272-2712(18)30023-4","article-title":"Toxins as weapons of mass destruction. A comparison and contrast with biological-warfare and chemical-warfare agents","volume":"21","author":"Madsen","year":"2001","journal-title":"Clin Lab Med"},{"key":"10.1016\/S1473-3099(02)00222-0_bib35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1084\/jem.189.1.89","article-title":"Identification and characterization of novel superantigens from Streptococcus pyogenes","volume":"189","author":"Proft","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/S1473-3099(02)00222-0_bib36","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1084\/jem.191.10.1765","article-title":"The streptococcal superantigen SMEZ exhibits wide allelic variation, mosaic structure, and significant antigenic variation","volume":"191","author":"Proft","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/S1473-3099(02)00222-0_bib37","first-page":"62","article-title":"Immunogenetic and biological aspects of in vitro lymphocyte allotransformation (MLR) in the mouse","volume":"15","author":"Festenstein","year":"1973","journal-title":"Transplant Rev"},{"key":"10.1016\/S1473-3099(02)00222-0_bib38","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1074-7613(01)00210-2","article-title":"Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen","volume":"15","author":"Sutkowski","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/S1473-3099(02)00222-0_bib39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1084\/jem.187.3.319","article-title":"Mycoplasma superantigen is a CDR3-dependent ligand for the T cell antigen receptor","volume":"187","author":"Hodtsev","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/S1473-3099(02)00222-0_bib40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jac\/40.2.275","article-title":"Comparative effects of clindamycin and ampicillin on superantigenic activity of Streptococcus pyogenes","volume":"40","author":"Sriskandan","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/S1473-3099(02)00222-0_bib41","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/00006454-199912000-00014","article-title":"Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection","volume":"18","author":"Zimbelman","year":"1999","journal-title":"Pediatr Infect Dis"},{"key":"10.1016\/S1473-3099(02)00222-0_bib42","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.4049\/jimmunol.156.8.3057","article-title":"Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production","volume":"156","author":"Norrby-Teglund","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/S1473-3099(02)00222-0_bib43","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1086\/515199","article-title":"Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome\u2014a comparative observational study. The Canadian Streptococcal Study Group","volume":"28","author":"Kaul","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S1473-3099(02)00222-0_bib44","article-title":"Intravenous immunoglobulin for treating sepsis and septic shock (Cochrane Review)","volume":"2","author":"Alejandria","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S1473-3099(02)00222-0_bib45","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1128\/IAI.69.2.875-884.2001","article-title":"Inhibition of bacterial superantigens by peptides and antibodies","volume":"69","author":"Visvanathan","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/S1473-3099(02)00222-0_bib46","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/74672","article-title":"Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation","volume":"6","author":"Arad","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/S1473-3099(02)00222-0_bib47","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/CMR.13.1.16","article-title":"Exotoxins of Staphylococcus aureus","volume":"13","author":"Dinges","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/S1473-3099(02)00222-0_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198907063210101","article-title":"Severe group A streptococcal infections associated with atoxic shock-like syndrome and scarlet fever toxin A","volume":"321","author":"Stevens","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/S1473-3099(02)00222-0_bib49","series-title":"Superantigens: molecular biology, immunology and relevance to human disease","first-page":"369","article-title":"Characerization of a superantigen produced by Yersinia pseudotuberculosis","author":"Abe","year":"1997"},{"key":"10.1016\/S1473-3099(02)00222-0_bib50","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1084\/jem.176.3.893","article-title":"Clostridium perfringens enterotoxin is a superantigen reactive with human T cell receptors V beta 6.9 and V beta 22.J","volume":"176","author":"Bowness","year":"1992","journal-title":"Exp Med"},{"key":"10.1016\/S1473-3099(02)00222-0_bib51","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1084\/jem.183.3.1105","article-title":"The sequence of the Mycoplasma arthritidis superantigen, MAM: identification of functional domains and comparison with microbial superantigens and plant lectin mitogens","volume":"183","author":"Cole","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/S1473-3099(02)00222-0_bib52","first-page":"358","article-title":"Anti-MAM antibodies in rheumatic disease: evidence for a MAM-like superantigen in rheumatoid arthritis?","volume":"27","author":"Sawitzke","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/S1473-3099(02)00222-0_bib53","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1128\/IAI.68.5.3048-3052.2000","article-title":"Recombinant Staphylococcus aureus exfoliative toxins are not bacterial superantigens","volume":"68","author":"Piano","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/S1473-3099(02)00222-0_bib54","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1128\/iai.64.3.987-994.1996","article-title":"Reactivity of mouse T-cell hybridomas expressing human Vbeta gene segments with staphylococcal and streptococcal superantigens","volume":"64","author":"Fleischer","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/S1473-3099(02)00222-0_bib55","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2307\/4444260","article-title":"Nothing in biology makes sense except in the light of evolution","volume":"35","author":"Dobzhansky","year":"1973","journal-title":"Am J Biol Teacher"},{"key":"10.1016\/S1473-3099(02)00222-0_bib56","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1365-2958.1998.00786.x","article-title":"High-frequency intracellular infection and erythrogenic toxin A expression undergo phase variation in Ml group A streptococci","volume":"28","author":"Cleary","year":"1998","journal-title":"Mol Microbiol"},{"key":"10.1016\/S1473-3099(02)00222-0_bib57","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1073\/pnas.071559398","article-title":"Complete genome sequence of an Ml strain of Streptococcus pyogenes","volume":"98","author":"Ferretti","year":"2001","journal-title":"Proc Natl Acad Sd USA"},{"key":"10.1016\/S1473-3099(02)00222-0_bib58","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-2249.1994.tb06620.x","article-title":"Streptococcal toxic shock like syndrome; evidence of superantigen activity and its effects on T lymphocyte subsets in vitro","volume":"98","author":"Michie","year":"1994","journal-title":"Clin Exp Immunology"},{"key":"10.1016\/S1473-3099(02)00222-0_bib59","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/infdis\/171.1.74","article-title":"Selective Depletion of V\u03b2- bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome","volume":"171","author":"Wantanabe-Ohnishi","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/S1473-3099(02)00222-0_bib60","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/A:1020547509410","article-title":"Superantigens in human disease","volume":"19","author":"Bernal","year":"1999","journal-title":"J Clin Immunol"},{"key":"10.1016\/S1473-3099(02)00222-0_bib61","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/eji.1830240227","article-title":"Differential effects of superantigen-induced \u201canergy\u201d on priming and effector stages of a T cell-dependent antibody response","volume":"24","author":"Lussow","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1016\/S1473-3099(02)00222-0_bib62","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1600-065X.1999.tb01297.x","article-title":"Understanding the mechanism of action of bacterial superantigens from a decade of research","volume":"168","author":"Lavoie","year":"1999","journal-title":"Immunol Rev"},{"key":"10.1016\/S1473-3099(02)00222-0_bib23","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0891-5520(05)70324-X","article-title":"The toxic shock syndromes","volume":"10","author":"Stevens","year":"1996","journal-title":"Infect Dis Clin North Am"}],"container-title":["The Lancet Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473309902002220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473309902002220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:56:58Z","timestamp":1761469018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473309902002220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["S1473309902002220"],"URL":"https:\/\/doi.org\/10.1016\/s1473-3099(02)00222-0","relation":{},"ISSN":["1473-3099"],"issn-type":[{"value":"1473-3099","type":"print"}],"subject":[],"published":{"date-parts":[[2002,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Superantigens: microbial agents that corrupt immunity","name":"articletitle","label":"Article Title"},{"value":"The Lancet Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S1473-3099(02)00222-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}